Cover Image
市場調查報告書

全球過敏診斷、治療市場

Global Markets for Allergy Diagnostics and Treatments

出版商 BCC Research 商品編碼 324154
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
全球過敏診斷、治療市場 Global Markets for Allergy Diagnostics and Treatments
出版日期: 2015年02月09日 內容資訊: 英文 130 Pages
簡介

全球過敏診斷、治療市場,預計從2014年的315億美元,到2015年增加到約353億美元。該市場預計從2015年到2020年的期間以5.8%的年複合成長率推移,到2020年達到468億美元。

本報告提供全球過敏診斷、治療市場相關調查、全球市場概要、市場趨勢、實際成果資料與預測,及年複合成長率預測的分析、各診斷、處方治療藥、OTC治療藥材類、地區的市場分析,及主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要

第3章 過敏概要

  • 過敏定義
  • 過敏和氣喘
  • 過敏和氣候變動
  • 過敏反應的種類
  • 過敏檢驗廠商
  • 免疫療法產品、廠商
  • 局部類固醇治療
  • 過敏性反應治療
  • 過敏結膜炎治療
  • 整體過敏治療
  • 過敏市場上M&A

第4章 全球過敏診斷市場

  • 過敏診斷產品市場預測
  • 診斷檢驗的種類
  • 地區市場
  • 南北美洲的過敏診斷市場預測
  • 歐洲、中東非洲的過敏診斷市場:各地區
  • 亞洲地區的過敏要素

第5章 全球免疫療法市場

  • SLIT(舌下免疫療法)給藥方法
  • SLIT的免疫變化
  • 皮下免疫療法和舌下免疫療法比較
  • 免疫療法產品
  • 免疫療法市場參與企業
  • 地區市場
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞洲

第6章 全球過敏治療市場

  • 全球過敏藥市場
  • 過敏處方藥
  • 過敏的學名藥
  • 美國的非專利產業
  • OTC過敏產品
  • 過敏藥物療法的種類
  • 抗組織胺藥物、抗組織胺化合物
  • 皮質類固醇過敏藥
  • 肥大細胞穩定劑
  • 白三烯受體
  • 過敏性反應治療
  • 過敏治療的地區市場
  • 南北美洲的過敏治療
  • 過敏率:各地區
  • 南北美洲的過敏治療市場
  • 過敏治療藥:各地區
  • 歐洲、中東、非洲的過敏治療

第7章 過敏檢驗、治療的開發及近幾年的專利

  • 診斷檢驗的新開發
  • 治療中的前進
  • 免疫療法
  • 專利

第8章 企業簡介

  • 診斷
  • 治療

圖表一覽

目錄
Product Code: PHM026B

REPORT HIGHLIGHTS

Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

This report provides:

  • An overview of the global markets for allergy diagnostics and treatments.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
  • Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
  • Profiles of major players in the allergy diagnostics and treatments industry.

SCOPE OF REPORT

This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market.

The report organizes information from diverse sources into a cohesive unit that includes:

  • A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
  • An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
  • Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
  • A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.

Prescription and over-the-counter (OTC) medications are further broken down into specific types of administration. Each subsegment is covered in depth with regard to oral, spray, topical, and ocular applications; current treatments, market size, and market participants; potential research and development; and forecasted market size and growth.

ANALYST'S CREDENTIALS

Peggy S. Lehr is the BCC research analyst of this report. Ms. Lehr holds a Bachelor of Science degree in Journalism from the University of Colorado, Boulder, and a Master of Science degree in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 25 years, and she has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include health care reports on catheters, magnetic resonance imaging, organ transplantation, asthma and chronic obstructive pulmonary disease (COPD), and autoimmune diseases, and her latest report on the global sterilization market.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • METHODOLOGY AND INFORMATION SOURCES
  • INTENDED AUDIENCE
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • ALLERGY TYPES
  • PROJECTED GLOBAL MARKET
    • GLOBAL ALLERGY DIAGNOSTIC MARKET
    • GLOBAL IMMUNOTHERAPY MARKET
    • GLOBAL ALLERGY MEDICATION MARKET
  • REGIONAL DIAGNOSTIC, IMMUNOTHERAPY, AND TREATMENT MARKET LEADERS
    • DIAGNOSTIC MARKET
    • IMMUNOTHERAPY MARKET
    • TREATMENT MARKET
  • SUMMARY TABLE: GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKETS BY TYPE, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY REGION, 2015 AND 2020 (%)

CHAPTER 3 - OVERVIEW OF ALLERGIES

  • DEFINITION OF ALLERGIES
  • ALLERGIES AND ASTHMA
  • ALLERGIES AND CLIMATE CHANGE
  • TYPES OF ALLERGIC REACTIONS
    • ENVIRONMENTAL ALLERGIES
      • Allergic Rhinitis
      • Rhinosinusitis
    • FOOD ALLERGIES
      • TABLE 1: MOST COMMON FOOD ALLERGIES IN THE U.S. AND EUROPE
      • Can Food Allergies be Outgrown?
      • Diagnosing Food Allergies
        • TABLE 2: FOOD ALLERGENS (IN ORDER OF DECREASING PREVALENCE) IN VARIOUS COUNTRIES
        • TABLE 3: TESTS FOR FOOD ALLERGIES
    • LATEX ALLERGIES
      • Diagnosis and Treatment of Latex Allergies
    • INSECT ALLERGIES
      • Diagnosis and Treatment
    • SKIN ALLERGIES
      • Atopic Eczema
      • Urticaria
        • TABLE 4: POTENTIAL TRIGGERS FOR HIVES
      • Angioedema
    • EYE ALLERGIES
      • Allergic Conjunctivitis
    • ALLERGIES TO DRUGS AND BIOLOGICAL AGENTS
  • ALLERGY TESTING MANUFACTURERS
    • TABLE 5: ALLERGY TESTING MANUFACTURERS BY COMPANY AND LOCATION
    • FIGURE 1: ALLERGY DIAGNOSTIC MANUFACTURER MARKET BY COUNTRY, 2014 (%)
  • IMMUNOTHERAPY PRODUCTS AND MANUFACTURERS
    • TABLE 6: ALLERGY IMMUNOTHERAPY MANUFACTURERS BY COMPANY AND TYPE OF PRODUCT
  • ALLERGY MEDICATION MANUFACTURERS
    • TABLE 7: ALLERGY MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
  • TOPICAL STEROID TREATMENTS
    • TABLE 8: TOPICAL STEROID MEDICATION MANUFACTURERS BY POTENCY, COMPANY, PRODUCT NAME, AND FORMULATION
  • ANAPHYLAXIS TREATMENTS
    • TABLE 9: ANAPHYLAXIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
  • ALLERGIC CONJUNCTIVITIS TREATMENTS
    • TABLE 10: ALLERGIC CONJUNCTIVITIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, AND FORMULATION
  • GENERIC ALLERGY TREATMENTS
    • TABLE 11: GENERIC ALLERGY MEDICATION MANUFACTURERS BY TYPE, PRODUCT NAME, FORMULATION, AND INDICATION
  • MERGERS AND ACQUISITIONS IN THE ALLERGY MARKET
    • TABLE 12: SELECTED MERGERS AND ACQUISITIONS PERTINENT TO THE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2009-2014

CHAPTER 4 - GLOBAL ALLERGY DIAGNOSTICS MARKET

  • PROJECTED MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS
    • TABLE 13: PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • FIGURE 2: PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC TESTING PRODUCTS BY TYPE, 2015 AND 2020 (%)
  • TYPES OF DIAGNOSTIC TESTS
    • SKIN TESTING
    • PROVOCATION TESTING
    • BLOOD ANALYSIS
      • Design of an Enzyme Immunoassay
    • BLOOD TESTING
      • Advantages and Disadvantages of Blood Testing
        • TABLE 14: APPROPRIATE TESTING FOR ALLERGIES BY TYPE OF ALLERGY AND TEST
  • REGIONAL MARKETPLACES
    • TABLE 15: PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • FIGURE 3: PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, 2015 AND 2020 (%)
  • PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTICS
    • TABLE 16: PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
    • FIGURE 4: PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
  • AMERICAS' ALLERGY DIAGNOSTIC MARKET BY REGION
    • U.S.
    • CANADA
    • CENTRAL AND SOUTH AMERICA
      • TABLE 17: PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
      • FIGURE 5: PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTICS
      • TABLE 18: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
      • FIGURE 6: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
  • EMRA'S ALLERGY DIAGNOSTIC MARKET BY REGION
    • EUROPE
    • MIDDLE EAST
    • AFRICA
    • PROJECTED EMRA ALLERGY DIAGNOSTIC MARKET
      • TABLE 19: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
      • FIGURE 7: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020
    • PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTICS
      • TABLE 20: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
      • FIGURE 8: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
    • ASIAN ALLERGY DIAGNOSTIC MARKET BY REGION
      • TABLE 21: COMPARATIVE POPULATION PREVALENCE OF DIAGNOSED NASAL ALLERGIES (%)
  • ALLERGIC TRIGGERS IN ASIAN REGION
    • JAPAN
    • CHINA
      • FIGURE 9: DIAGNOSIS FOR ALLERGIC RHINITIS IN CHINA (%)
    • INDIA
    • PROJECTED ASIAN ALLERGY DIAGNOSTIC MARKET
      • TABLE 22: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
      • FIGURE 10: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)

CHAPTER 5 - GLOBAL IMMUNOTHERAPY MARKET

  • TABLE 23: PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • FIGURE 11: PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
  • SLIT ADMINISTRATION APPROACH
  • IMMUNOLOGIC CHANGES FOLLOWING SLIT
  • COMPARISON OF SUBCUTANEOUS IMMUNOTHERAPY AND SUBLINGUAL IMMUNOTHERAPY
    • SINGLE ANTIGEN VERSUS MULTI-ANTIGEN THERAPY
  • IMMUNOTHERAPY PRODUCTS
    • TABLE 24: ALLERGEN SUBLINGUAL AND INJECTABLE ALLERGEN EXTRACT IMMUNOTHERAPY TREATMENTS
  • IMMUNOTHERAPY MARKET PARTICIPANTS
    • FIGURE 12: MARKET ANALYSIS FOR IMMUNOTHERAPY PRODUCTS BY PARTICIPANT, 2012 (%)
  • REGIONAL MARKETS
    • TABLE 25: PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • FIGURE 13: PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, 2015 AND 2020 (%)
  • AMERICAS
    • TABLE 26: PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 14: PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • U.S.
    • Brazil
  • EMRA
    • TABLE 27: PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 15: PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • Western Europe
    • Middle East
  • ASIA
    • TABLE 28: PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • FIGURE 16: PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • Japan
    • China

CHAPTER 6 - GLOBAL ALLERGY TREATMENT MARKET

  • GLOBAL MARKET FOR ALLERGY PRODUCTS
    • TABLE 29: PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • FIGURE 17: PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
  • PRESCRIPTION ALLERGY PRODUCTS
    • TABLE 30: PROJECTED GLOBAL MARKET FOR PRESCRIPTION ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • GENERIC ALLERGY PRODUCTS
    • MARKET DRIVERS
    • GLOBAL GENERIC ALLERGY MARKET
      • TABLE 31: PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 18: PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
  • GENERIC INDUSTRY IN THE U.S.
  • OTC ALLERGY PRODUCTS
    • TABLE 32: PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 19: PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
  • TYPES OF ALLERGY MEDICATIONS
    • TABLE 33: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • FIGURE 20: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, 2015 AND 2020 (%)
  • ANTIHISTAMINES AND ANTIHISTAMINE COMBINATIONS
    • Benefits/Disadvantages
    • Antihistamine Products
      • TABLE 34: ANTIHISTAMINE AND ANTIHISTAMINE COMBINATION PRODUCTS, 2014
    • Market Size for Antihistamines and Antihistamine Combinations
      • TABLE 35: PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
      • FIGURE 21: PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
  • SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS
    • Overview
    • Benefits/Disadvantages
      • TABLE 36: AVAILABLE SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY NAME AND MANUFACTURER, 2014
    • Sympathomimetics, Decongestants and Combinations Market Size
      • TABLE 37: PROJECTED GLOBAL MARKET FOR SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • CORTICOSTEROID ALLERGY PRODUCTS
    • Overview
    • Benefits/Disadvantages
      • TABLE 38: CORTICOSTEROID PREPARATIONS BY NAME AND MANUFACTURER
    • Corticosteroid Market Size
      • TABLE 39: PROJECTED GLOBAL MARKET FOR ALLERGY CORTICOSTEROIDS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
  • MAST CELL STABILIZERS
    • Overview
      • TABLE 40: PROJECTED GLOBAL MARKET FOR ALLERGY MAST CELL STABILIZERS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
      • TABLE 41: SELECTED MAST CELL STABILIZER ALLERGY PRODUCTS BY NAME AND MANUFACTURER
  • LEUKOTRIENE RECEPTORS
    • TABLE 42: PROJECTED GLOBAL MARKET FOR LEUKOTRIENE RECEPTOR TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
  • ANAPHYLAXIS TREATMENT
    • TABLE 43: PROJECTED GLOBAL MARKET FOR ANAPHYLAXIS TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
  • REGIONAL MARKETS FOR ALLERGY TREATMENTS
    • TABLE 44: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 22: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, 2015 AND 2020 (%)
  • ALLERGY TREATMENT IN THE AMERICAS
    • U.S. ALLERGY TREATMENT MARKET
      • Treatment Costs
        • TABLE 45: ESTIMATED COSTS FOR TREATING ALLERGIES IN THE U.S., 2012 ($ BILLIONS)
      • Allergic Reactions
        • FIGURE 23: ALLERGY DEMOGRAPHICS BY TYPE OR CAUSE, 2012 (%)
      • Allergy Population in the U.S.
      • Regional Variations
        • TABLE 46: WORST U.S. CITIES FOR ALLERGIES BY ALLERGEN, 2011
      • Sensitization by Gender
      • Sensitization by Age
        • FIGURE 24: PROJECTED PERCENTAGE OF U.S. POPULATION WITH AND WITHOUT ALLERGIES, 2015 AND 2020 (%)
  • ALLERGY RATES BY REGION
    • FIGURE 25: REGIONS/COUNTRIES WITHIN THE AMERICAS WITH HIGHEST CONCENTRATIONS OF DIAGNOSED ALLERGY CASES, 2013 (%)
  • AMERICAS ALLERGY TREATMENT MARKET
    • TABLE 47: PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • FIGURE 26: PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
    • TABLE 48 PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
  • ALLERGY TREATMENT PRODUCTS BY REGION
    • TABLE 49: PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • South and Central American Treatment Market
  • ALLERGY TREATMENT IN THE EMRA
    • ALLERGIES IN EUROPE
    • PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY PRODUCTS
      • TABLE 50: PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
      • FIGURE 27: PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
      • TABLE 51: PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • RUSSIA
      • TABLE 52: PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • ALLERGY TREATMENT IN ASIA
      • TABLE 53: PROJECTED ASIA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • JAPAN
    • CHINA
      • Treatment Satisfaction in China
    • INDIA
      • TABLE 54: MEDICATIONS FOR ALLERGY TREATMENT IN INDIA BY NAME, TYPE AND CONDITION, 2014
    • AUSTRALIA/NEW ZEALAND
    • PROJECTED ASIAN MARKET FOR ALLERGY PRESCRIPTION, GENERIC, AND OTC PRODUCTS BY REGION
      • TABLE 55: PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
      • FIGURE 28: PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)

CHAPTER 7 - DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT AND RECENT PATENTS

  • NEW DEVELOPMENTS IN DIAGNOSTIC TESTING
    • ALLERGEN COMPONENT-RESOLVED DIAGNOSTICS
  • ADVANCES IN TREATMENTS
    • CHINESE HERBAL MEDICINE
  • IMMUNOTHERAPY
    • ANERGIS
    • B CELL EPITOPE-BASED IMMUNOTHERAPY
    • NASAL FILTERS
  • PATENTS
    • DIAGNOSIS
      • U.S. Patent: 8,563,258
    • TREATMENT
      • U.S. Patent: 8,859,575
      • U.S. Patent: 8,859,550
      • U.S. Patent: 8,859,505
      • U.S. Patent: 8,858,974
      • U.S. Patent: 8,858,944
      • U.S. Patent: 8,853,375
      • U.S. Patent: 8,835,603
      • U.S. Patent: 8,829,005
      • U.S. Patent: 8,822,39
      • U.S. Patent: 8,815,258
      • U.S. Patent: 8,809,527
      • U.S. Patent: 8,809,524
      • U.S. Patent: 8,796,225
      • U.S. Patent: 8,795,705
      • U.S. Patent: 8,795,666
      • U.S. Patent: 8,790,643
      • U.S. Patent: 8,785,393
      • U.S. Patent: 8,778,344
      • U.S. Patent: 8,763,604
      • U.S. Patent: 8,759,403
      • U.S. Patent: 8,748,126
      • U.S. Patent: 8,747,813
      • U.S. Patent: 8,741,323
      • U.S. Patent: 8,734,783
      • U.S. Patent: 8,722,883
      • U.S. Patent: 8,703,144
      • U.S. Patent: 8,697,869
      • U.S. Patent: 8,697,083
      • U.S. Patent: 8,664,215
      • U.S. Patent: 8,663,695
      • U.S. Patent: 8,658,637
      • U.S. Patent: 8,658,630
      • U.S. Patent: 8,637,037
      • U.S. Patent: 8,632,775
      • U.S. Patent: 8,628,946
      • U.S. Patent: 8,592,381
      • U.S. Patent: 8,591,907
      • U.S. Patent: 8,580,829
      • U.S. Patent: 8,575,181
      • U.S. Patent: 8,575,165
      • U.S. Patent: 8,575,158
      • U.S. Patent: 8,574,630
      • U.S. Patent: 8,574,564

CHAPTER 8 - COMPANY PROFILES

  • DIAGNOSTICS
    • ALERE
    • ALK-ABELLO A/S
    • ALLERGY LABORATORIES INC.
    • ALLERGOPHARMA AG
    • ANI BIOTECH OY
    • BECKMAN COULTER/DANAHER
    • BIOMERICA
    • DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
    • FIRST DIAGNOSTIC LLC
    • GREER HUMAN ALLERGY
    • HAL ALLERGY
    • HOLLISTER-STIER ALLERGY
    • HITACHI CHEMICAL DIAGNOSTICS INC.
    • HYCOR BIOMEDICAL
    • LABCORP OF AMERICA
    • LINCOLN DIAGNOSTICS
    • QUEST DIAGNOSTICS
    • SIEMENS HEALTHCARE
    • SMARTPRACTICE DENMARK
    • TERUMO MEDICAL PRODUCTS
    • THERMO FISHER DIAGNOSTICS (IMMUNODIAGNOSTICS)
  • TREATMENTS
    • ALCON LABORATORIES
    • ALK-ABELLO A/S
    • ALLERGEN PHARMACEUTICALS
    • AMEDRA PHARMACEUTICALS LLC
    • AQUA PHARMACEUTICALS
    • FERNDALE PHARMA GROUP (FERNDALE HEALTHCARE)
    • GLADERMA S.A.
    • GLAXOSMITHKLINE
    • JOHNSON & JOHNSON
    • KYOWA HAKKO KIRIN PHARMA INC.
    • LUPIN LTD.
    • MEDA AB
    • MERCK
    • MYLAN INC.
    • PFIZER
    • PIERRE FABRE MEDICAMENT
    • RANBAXY LABORATORIES
    • ROCHE
    • SANDOZ INTERNATIONAL GMBH
    • SANOFI
    • STALLERGENES AS
    • TARO PHARMACEUTICAL INDUSTRIES
    • UCB PHARMA LTD.

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKETS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: MOST COMMON FOOD ALLERGIES IN THE U.S. AND EUROPE
    • TABLE 2: FOOD ALLERGENS (IN ORDER OF DECREASING PREVALENCE) IN VARIOUS COUNTRIES
    • TABLE 3: TESTS FOR FOOD ALLERGIES
    • TABLE 4: POTENTIAL TRIGGERS FOR HIVES
    • TABLE 5: ALLERGY TESTING MANUFACTURERS BY COMPANY AND LOCATION
    • TABLE 6: ALLERGY IMMUNOTHERAPY MANUFACTURERS BY COMPANY AND TYPE OF PRODUCT
    • TABLE 7: ALLERGY MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
    • TABLE 8: TOPICAL STEROID MEDICATION MANUFACTURERS BY POTENCY, COMPANY, PRODUCT NAME, AND FORMULATION
    • TABLE 9: ANAPHYLAXIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, FORMULATION, AND INDICATION FOR USE OF PRODUCT
    • TABLE 10: ALLERGIC CONJUNCTIVITIS MEDICATION MANUFACTURERS BY COMPANY, PRODUCT NAME, TYPE, AND FORMULATION
    • TABLE 11: GENERIC ALLERGY MEDICATION MANUFACTURERS BY TYPE, PRODUCT NAME, FORMULATION, AND INDICATION
    • TABLE 12: SELECTED MERGERS AND ACQUISITIONS PERTINENT TO THE ALLERGY DIAGNOSTIC AND TREATMENT MARKET, 2009-2014
    • TABLE 13: PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: APPROPRIATE TESTING FOR ALLERGIES BY TYPE OF ALLERGY AND TEST
    • TABLE 15: PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 18: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
    • TABLE 19: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, THROUGH 2020 ($ MILLIONS)
    • TABLE 21: COMPARATIVE POPULATION PREVALENCE OF DIAGNOSED NASAL ALLERGIES (%)
    • TABLE 22: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 24: ALLERGEN SUBLINGUAL AND INJECTABLE ALLERGEN EXTRACT IMMUNOTHERAPY TREATMENTS
    • TABLE 25: PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 26: PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 28: PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 30: PROJECTED GLOBAL MARKET FOR PRESCRIPTION ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: ANTIHISTAMINE AND ANTIHISTAMINE COMBINATION PRODUCTS, 2014
    • TABLE 35: PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: AVAILABLE SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY NAME AND MANUFACTURER, 2014
    • TABLE 37: PROJECTED GLOBAL MARKET FOR SYMPATHOMIMETICS, DECONGESTANTS AND COMBINATIONS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: CORTICOSTEROID PREPARATIONS BY NAME AND MANUFACTURER
    • TABLE 39: PROJECTED GLOBAL MARKET FOR ALLERGY CORTICOSTEROIDS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: PROJECTED GLOBAL MARKET FOR ALLERGY MAST CELL STABILIZERS BY FORM OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: SELECTED MAST CELL STABILIZER ALLERGY PRODUCTS BY NAME AND MANUFACTURER
    • TABLE 42: PROJECTED GLOBAL MARKET FOR LEUKOTRIENE RECEPTOR TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: PROJECTED GLOBAL MARKET FOR ANAPHYLAXIS TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 45: ESTIMATED COSTS FOR TREATING ALLERGIES IN THE U.S., 2012 ($ BILLIONS)
    • TABLE 46: WORST U.S. CITIES FOR ALLERGIES BY ALLERGEN, 2011
    • TABLE 47: PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 48: PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: PROJECTED AMERICAS MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: PROJECTED EMRA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)
    • TABLE 53: PROJECTED ASIA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, THROUGH 2020 ($ MILLIONS)
    • TABLE 54: MEDICATIONS FOR ALLERGY TREATMENT IN INDIA BY NAME, TYPE AND CONDITION, 2014
    • TABLE 55: PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, THROUGH 2020 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT MARKET BY REGION, 2015 AND 2020 (%)
    • FIGURE 1: ALLERGY DIAGNOSTIC MANUFACTURER MARKET BY COUNTRY, 2014 (%)
    • FIGURE 2: PROJECTED GLOBAL MARKET FOR ALLERGY DIAGNOSTIC TESTING PRODUCTS BY TYPE, 2015 AND 2020 (%)
    • FIGURE 3: PROJECTED REGIONAL MARKETS FOR ALLERGY DIAGNOSTIC PRODUCTS, 2015 AND 2020 (%)
    • FIGURE 4: PROJECTED AMERICAS MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
    • FIGURE 5: PROJECTED AMERICAS' MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • FIGURE 6: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
    • FIGURE 7: PROJECTED EMRA MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020
    • FIGURE 8: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY TYPE OF TEST, 2015 AND 2020 (%)
    • FIGURE 9: DIAGNOSIS FOR ALLERGIC RHINITIS IN CHINA (%)
    • FIGURE 10: PROJECTED ASIAN MARKET FOR ALLERGY DIAGNOSTIC PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • FIGURE 11: PROJECTED GLOBAL MARKET FOR IMMUNOTHERAPY ALLERGY PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
    • FIGURE 12: MARKET ANALYSIS FOR IMMUNOTHERAPY PRODUCTS BY PARTICIPANT, 2012 (%)
    • FIGURE 13: PROJECTED REGIONAL MARKETS FOR IMMUNOTHERAPY PRODUCTS, 2015 AND 2020 (%)
    • FIGURE 14: PROJECTED AMERICAS MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • FIGURE 15: PROJECTED EMRA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • FIGURE 16: PROJECTED ASIA MARKET FOR IMMUNOTHERAPY PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
    • FIGURE 17: PROJECTED GLOBAL MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
    • FIGURE 18: PROJECTED GLOBAL MARKET FOR GENERIC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
    • FIGURE 19: PROJECTED GLOBAL MARKET FOR OTC ALLERGY TREATMENT PRODUCTS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
    • FIGURE 20: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY TYPE, 2015 AND 2020 (%)
    • FIGURE 21: PROJECTED GLOBAL MARKET FOR ANTIHISTAMINE AND ANTIHISTAMINE COMBINATIONS BY FORM OF ADMINISTRATION, 2015 AND 2020 (%)
    • FIGURE 22: PROJECTED GLOBAL MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION, 2015 AND 2020 (%)
    • FIGURE 23: ALLERGY DEMOGRAPHICS BY TYPE OR CAUSE, 2012 (%)
    • FIGURE 24: PROJECTED PERCENTAGE OF U.S. POPULATION WITH AND WITHOUT ALLERGIES, 2015 AND 2020 (%)
    • FIGURE 25: REGIONS/COUNTRIES WITHIN THE AMERICAS WITH HIGHEST CONCENTRATIONS OF DIAGNOSED ALLERGY CASES, 2013 (%)
    • FIGURE 26: PROJECTED AMERICAS MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
    • FIGURE 27: PROJECTED EMRA MARKET FOR PRESCRIPTION, GENERIC, AND OTC ALLERGY TREATMENT PRODUCTS, 2015 AND 2020 (%)
    • FIGURE 28: PROJECTED ASIA MARKET FOR ALLERGY TREATMENT PRODUCTS BY REGION/COUNTRY, 2015 AND 2020 (%)
Back to Top